image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Heath

September 2009

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 552p
In a short but positive update at its AGM, Synergy Health noted trading remains in line with expectations with sales in the first quarter increasing 9.7% to £72.6m. The spilt geographically was UK up 1%, Europe rising 22% and the fledgling Asia / South Africa side increasing almost 18%. Net debt reduced by £17m to £153m. Broker Brewin Dolphin notes that on a 12-month basis there is a good chance of further positive news flow and has moved to a buy recommendation with a 600p price target, which would equate to a prospective PE of 14.6 based on forecast eps of 41.1p. Continue to buy. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X